Predictive Models Based on Molecular Images and Molecular Descriptors for Drug Screening
Open Access
- 13 September 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (40) , 37186-37195
Abstract
Various toxicity and pharmacokinetic evaluations as screening experiments are needed at the drug discovery stage. Currently, to reduce the use of animal experiments and developmental expenses, the development of high-performance predictive models based on quantitative structure-activity relationship analysis is desired. From these evaluation targets, we selected 50% lethal dose (LD50), blood-brain barrier penetration (BBBP), and the clearance (CL) pathway for this investigation and constructed predictive models for each target using 636-11,886 compounds. First, we constructed predictive models using the DeepSnap-deep learning (DL) method and images of compounds as features. The calculated area under the curve (AUC) and balanced accuracy (BAC) were, respectively, 0.887 and 0.818 for LD50, 0.893 and 0.824 for BBBP, and 0.883 and 0.763 for the CL pathway. Next, molecular descriptors (MDs) of compounds were calculated using Molecular Operating Environment, alvaDesc, and ADMET Predictor to construct predictive models using the MD-based method. Using these MDs, we constructed predictive models using DataRobot. The calculated AUC and BAC were, respectively, 0.931 and 0.805 for LD50, 0.919 and 0.849 for BBBP, and 0.900 and 0.807 for the CL pathway. In this investigation, we constructed predictive models combining the DeepSnap-DL and MD-based methods. In ensemble models using the mean predictive probability of the DeepSnap-DL and MD-based methods, the calculated AUC and BAC were, respectively, 0.942 and 0.842 for LD50, 0.936 and 0.853 for BBBP, and 0.908 and 0.832 for the CL pathway, with improved predictive performance observed for all variables compared with either single method alone. Moreover, in consensus models that adopted only compounds for which the results of the two methods agreed, the calculated BAC for LD50, BBBP, and the CL pathway were 0.916, 0.918, and 0.847, respectively, indicating higher predictive performance than the ensemble models for all three variables. The predictive models combining the DeepSnap-DL and MD-based methods displayed high predictive performance for LD50, BBBP, and the CL pathway. Therefore, the application of this approach to prediction targets in various drug discovery screenings is expected to accelerate drug discovery.Keywords
This publication has 44 references indexed in Scilit:
- Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)Pharmaceutical Research, 2015
- Caffe2014
- Clearance Mechanism Assignment and Total Clearance Prediction in Human Based upon in Silico ModelsJournal of Medicinal Chemistry, 2014
- Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs by Using Various Cheminformatics ApproachesPharmaceutical Research, 2013
- A Bayesian Approach to in Silico Blood-Brain Barrier Penetration ModelingJournal of Chemical Information and Modeling, 2012
- In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS HitsChemMedChem, 2006
- Effect of Selection of Molecular Descriptors on the Prediction of Blood−Brain Barrier Penetrating and Nonpenetrating Agents by Statistical Learning MethodsJournal of Chemical Information and Modeling, 2005
- Development and Validation of k-Nearest-Neighbor QSPR Models of Metabolic Stability of Drug CandidatesJournal of Medicinal Chemistry, 2003
- A general pattern for substrate recognition by P‐glycoproteinEuropean Journal of Biochemistry, 1998
- The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism DataThe Journal of Pharmacology and Experimental Therapeutics, 1997